Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.83
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
Via
Benzinga
Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?
December 25, 2023
Some of this year's underperformers could have brighter futures.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Blue-Chip Stocks Set for a 50% Surge in the Coming Year
December 25, 2023
These are the attractively valued blue-chip stocks to buy as they represent companies with a positive outlook for 2024.
Via
InvestorPlace
Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?
December 23, 2023
Is Pfizer stock a bargain buy?
Via
The Motley Fool
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
December 23, 2023
The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
Via
The Motley Fool
Exposures
COVID-19
Unpacking the Latest Options Trading Trends in Pfizer
December 21, 2023
Via
Benzinga
The Top Healthcare Stocks to Buy With $100
December 21, 2023
These stocks haven't been popular with investors lately.
Via
The Motley Fool
Better Dividend Stock: Pfizer or British American Tobacco?
December 20, 2023
Both blue chip dividend stocks are prized for their rich payouts.
Via
The Motley Fool
HBM Gets Health Boost From Drug Licensing Deals
December 22, 2023
Key Takeaways: Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05...
Via
Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
Which weight-loss stocks are good buys today?
Via
The Motley Fool
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock
December 21, 2023
These stocks are currently going in different directions, but both could go up in a new bull market.
Via
The Motley Fool
Thoughts For Thursday: Everything That Goes Up Comes Down
December 21, 2023
Yesterday, the market closed observably down. There are all sorts of reasons why; technical trading, geopolitical worries, Wall St. types heading out for X-mas, in a word, momentum.
Via
Talk Markets
Three Safe Dividend Paying Stocks With High Yields To Hold In 2024
December 20, 2023
Three companies dominate their domains for high dividend yields.
Via
Talk Markets
Why Pfizer Stock Is Bouncing Back
December 19, 2023
I think Pfizer stock looks kinda cheap.
Via
The Motley Fool
Why Pfizer Stock Was a Winner on Monday
December 18, 2023
The company received its latest U.S. regulatory green light.
Via
The Motley Fool
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n
Via
Benzinga
Exposures
COVID-19
Insiders Buying Pfizer And 3 Other Stocks
December 20, 2023
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Want $1,500 in Dividend Income in 2024? Invest $25,000 in These 3 Top Income Stocks
December 20, 2023
These stocks are relatively safe buys with strong positions in their respective industries.
Via
The Motley Fool
3 Stocks Near Multiyear Lows That Could Bounce Back in 2024
December 20, 2023
If you're a contrarian investor, these are stocks you'll want to consider adding to your portfolio.
Via
The Motley Fool
3 Stocks to Snatch Up on Tax-Loss Harvesting Dips
December 19, 2023
Are you looking for stocks during the tax-loss harvesting? Here are three stocks to snatch up on tax-loss selling dips.
Via
InvestorPlace
Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now
December 19, 2023
Avoid these f-rated stocks like the plague in order to help keep your portfolio squeaky clean in the new year.
Via
InvestorPlace
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
December 19, 2023
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...
Via
Benzinga
Most Active Equity Options For Midday - Tuesday, Dec. 19
December 19, 2023
Via
Talk Markets
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
December 19, 2023
A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) related to seeking fair compensation for infringement of a portfolio of
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
5 of the Safest High-Yield Dividend Stocks to Buy for 2024
December 19, 2023
These supercharged dividend stocks, with yields ranging from 5.4% to 10.5%, offer highly favorable risk-versus-reward profiles for income seekers in the new year.
Via
The Motley Fool
3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?
December 18, 2023
Investors still need to look at the business when searching for stocks to buy at a 52-week low because the business model may be broken.
Via
InvestorPlace
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
Most Active Equity Options For Midday - Monday, Dec. 18
December 18, 2023
Here are the most active equity options for midday.
Via
Talk Markets
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
December 18, 2023
It's no secret that the next couple of years will be slow.
Via
The Motley Fool
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
2024 is going to be a sizzler in the biopharma sector.
Via
The Motley Fool
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.